Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Arthritis Research & Therapy

Figure 3

From: The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation

Figure 3

Viability values in bone marrow stromal cells. Difference of viability (XTT test) with respect to controls expressed in percentage in bone marrow stromal cells treated with risedronate (Ris) at different concentrations, with or without NS-398 COX-2 inhibitor (a) and with dexametasone 1 μM (DEX) (b) with or without risedronate (Ris) at different concentrations. The experiments were performed in triplicate.

Back to article page